Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria

Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria

US Patent 7625572 · Granted Dec 1, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for preventing and treating coronavirus infection—SARS-2022
Compositions and methods for preventing and treating coronavirus infection—SARS-2022
Methods and compositions for inducing protective immunity against RSV infection2022
Method for the safe induction of immunity against RSV2022
Therapeutic vaccination against active Tuberculosis2014
Malaria vaccine compositions and constituents which elicit cell mediated immunit2014
Methods to increase transgene expression from bacterial-based delivery systems b2014
Multivalent vaccines comprising recombinant viral vectors2013
Multivalent vaccines comprising recombinant viral vectors2013
Methods to increase transgene expression from bacterial-based delivery systems b2013
Recombinant BCG tuberculosis vaccine designed to elicit immune responses to myco2013
Multivalent vaccines comprising recombinant viral vectors2012